Advances in Medical Imaging Technology for Accurate Detection of Prostate Cancer
Prostate cancer (PCa) is the most frequently diagnosed non-cutaneous male malignancy and one of the leading causes of cancer-related mortality in the United States. Biologic heterogeneity of PCa results is different presentations ranging from indolent to highly aggressive tumors with high morbidity...
Saved in:
| Main Author: | |
|---|---|
| Format: | Ebooks |
| Published: |
IntechOpen,
2018-09-26.
|
| Subjects: | |
| Online Access: | Get Online |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 02175 am a22001933u 4500 | ||
|---|---|---|---|
| 001 | intechopen_books_6423 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Ziaei, Alireza |e author |
| 245 | 0 | 0 | |a Advances in Medical Imaging Technology for Accurate Detection of Prostate Cancer |
| 260 | |b IntechOpen, |c 2018-09-26. | ||
| 500 | |a https://mts.intechopen.com/articles/show/title/advances-in-medical-imaging-technology-for-accurate-detection-of-prostate-cancer | ||
| 520 | |a Prostate cancer (PCa) is the most frequently diagnosed non-cutaneous male malignancy and one of the leading causes of cancer-related mortality in the United States. Biologic heterogeneity of PCa results is different presentations ranging from indolent to highly aggressive tumors with high morbidity and mortality. Due to this broad range of clinical behavior, it is required to differentiate clinically significant PCa (csPCa) tumors and reduce detection of indolent cancers. PCa is generally diagnosed with non-targeted systematic trans-rectal ultrasound (TRUS)-guided biopsy in patients with elevated prostate serum antigen (PSA) or abnormal digital rectal examination (DRE). Non-targeted systematic TRUS as the typical imaging modality for assessing the prostate, samples only a small part of the gland with a high possibly that the biopsy results may not catch the most aggressive tumor in the gland accurately. Multi-parametric (MP) magnetic resonance imaging (MRI), as the most specific and sensitive imaging modality in PCa management, has been reported to be the reference standard for prostate imaging endorsed. However, there are a variety of interpretive pitfalls, which have been reported to be encountered at mpMRI of the prostate. The purpose of this chapter is to provide a summary of the current advances in accurate detection of PCa. | ||
| 540 | |a https://creativecommons.org/licenses/by/3.0/ | ||
| 546 | |a en | ||
| 690 | |a Prostate Cancer | ||
| 655 | 7 | |a Chapter, Part Of Book |2 local | |
| 786 | 0 | |n https://www.intechopen.com/books/6423 | |
| 787 | 0 | |n ISBN:978-1-78923-999-7 | |
| 856 | \ | \ | |u https://mts.intechopen.com/articles/show/title/advances-in-medical-imaging-technology-for-accurate-detection-of-prostate-cancer |z Get Online |